Randomization for Replicate design studies [Design Issues]

posted by mmw – India, 2020-04-18 15:43 (1025 d 00:24 ago) – Posting: # 21334
Views: 3,939

Dear All,

Once of the clients want to conduct the partial replicate BE study with two test products (T1 & T2) in comparison with reference product (R). It would be four-period study (T1T2RR).

My question is that what would be the appropriate sequences for this four period study.

Your advice in this regard highly appreciated.

Thanks in advance.

MMW

Complete thread:

UA Flag
Activity
 Admin contact
22,485 posts in 4,710 threads, 1,603 registered users;
22 visitors (0 registered, 22 guests [including 7 identified bots]).
Forum time: 15:07 CET (Europe/Vienna)

The difference between a surrogate and a true endpoint
is like the difference between a cheque and cash.
You can get the cheque earlier but then,
of course, it might bounce.    Stephen Senn

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5